The acid saline extract (ASE) of rat submaxillary gland exerts a powerful degrading effect on 125I-glucagon. In order to study the degradation of other 125I-peptides by ASE and the effects of their inhibitors , 125I-pancreatic polypeptide (PP) and 125I-insulin were used together with 125I-glucagon. The degradation studies were done by the trichloroacetic acid (TCA) method or gel in the ordinary immunoassay system using the TCA method, but 125I-insulin was intact in the presence of ASE. Leupeptin, and to a lesser extent pchloromercuriphenyl-sulfonic acid (PCMS) and N-ethylmaleimide, inhibited the destruction of 125I-glucagon or -PP under the TCA method. PCMS was especially protective at high concentrations, for example 16 mM. These findings were confirmed by gel filtration of the assay mixture. In the presence of leupeptin (0.4mM) and PCMS (16mM), no shift in the peak of labelled glucagon or PP occurred. Thus ASE degrades not only 125I-glucagon but -PP, and thiol proteinase inhibitors have a strong inhibitory action on them.
Large amounts of glucagon-like substances have been reported in acid saline extracts of the submaxillary gland of the rat, mouse and rabbit (Bhathena et al., 1974; Silverman and Dunbar, 1974; Lawrence et al., 1976; Dunbar et al., 1976; Paulo et al., 1986) . In addition, immunocytochemical studies have shown glucagonlike peptides in the rat salivary gland (Smith and Tomo, 1986) . However, recent studies have revealed that salivary gland glucagon is a fictitious substance (Tahara et al., 1983; Tominaga et al., 1984) since tracer glucagon added to the assay system is largely degraded, even in the presence of aprotinin.
These investigations prompted us to study the degradation of tracers of pancreatic hormones other than glucagon and the effects of proteinase inhibitors on them using acid saline extracts of the rat submaxillary gland, thus contributing to the clarification of the nature of proteolytic enzymes in ASE. (1976) , and the degradation of 125I-glucagon and -PP was investigated by the TCA precipitation method in each fraction.
In the degradation studies using proteinase inhibitors, the inhibitors were added in the incubation medium together with labelled hormone and ASE.
Leupeptin cm) (Fig. 2) . Active destruction of 1251-glucagon and -PP was found in the same fraction.
Protection of 125 1-glucagon and 125I-PP by proteinase inhibitors The effects of leupeptin, PCMS and Nethylmaleimide as proteinase inhibitors on the destruction of 125I-glucagon and 125I-PP were studied (Tables 1 and 2 ). Without proteinase inhibitors, the percentage of radioactivity in the TCA precipitate was 44.0% with 0.1ml of a 104-fold dilution of ASE in the 1251-glucagon; it was increased to 58.3% in the presence of 0.4mM leupeptin.
At a 16mM concentration of PCMS, the degradation of 125I-glucagon was completely inhibited.
The degradation of 125I-PP by ASE was also inhibited by leupeptin and PCMS. The percentage of radioactivity of the TCA precipitate was 35.7% with 0.1ml of a 200-fold dilution of ASE, it was increased to 63.6% and 81.5% in the presence of 0.4mM of leupeptin and 16mM of PCMS, respectively, and to 97.2% in the presence of both inhibitors. N-ethylmaleimide had a less inhibitory effect.
Gel filtration of 125I-glucagon, -PP and -insulin
As shown in Fig. 3 , the peak of 125I-glucagon in the medium containing ASE was shifted to the smaller molecular weight fraction, but no shift in the peak of 1251-glucagon was found in the incubation medium containing leupeptin and PCMS. Leupeptin plus PCMS also protected against the degradation of 125I-PP by ASE (Fig. 4) . No shift in 125I-insulin was found, even at high concentrations of ASE in the assay system (0.1ml, 200-fold dilution) (Fig. 5 ).
Discussion
In this study, we found that not only 125I-glucagon but also 125I-PP was destroyed by ASE. In contrast, 125I-insulin was intact in the presence of ASE. The gel filtration study of ASE revealed that the molecular weights of the proteolytic enzymes of 125I-glucagon and -PP were similar. Tsubouchi et al. (1983) reported that so-called "big plasma glucagon" (BPG) might be due to Table  1 .
Protective effect of leupeptin, PCMS and A-ethylmaleimide on destruction of 125-glucagon caused by its incubation with ASE. Various amounts of the agents indicated in the second column were added to a mixture of 125I-glucagon and ASE. Intact 125I-glucagon was expressed as a percent of total radioactivity in the precipitate(TCA method). Protective effect of leupeptin, PCMS and N-ethylmaleimide on destruction of 125I-PP caused by its incubation with ASE. Various amounts of the agents indicated in the second column were added to a mixture of 125I-PP and ASE. Intact 125I-PP was expressed as a percent of total radioactivity in the precipitate (TCA method).
the degradation of 125I-glucagon during the incubation period of radioimmunoassay, and the destruction of labelled glucagon would give rise to the presence of false BPG. Although gel filtration of such degraded 125I-glucagon has not been done in the above paper, it is possible that a similar gel filtration pattern would be obtained.
Aprotinin, a serine proteinase inhibitor, had no inhibitory effect. Hatton et al. (1982) reported the marked degradation of 125I-glucagon by ASE from rat brain in spite of the presence of aprotinin, pepstatin, EDTA or phenylmethylsulfonylfluoride.
In our experiment, aprotinin had no inhibitory effect on either 125I-glucagon or -PP degradation (unpublished results), wherease thiol proteinase inhibitors such as PCMS or Nethylmaleimide had a strong effect on them, just as on the proteolytic activity in the BPG fraction of serum (Tsubouchi et al., 1983) .
The degradation of 125I-glucagon by ASE is thought to occur at the arg-arg bond of the 17th and 18th of 29 peptides (Tahara et al., 1983) . In this experiment bovine 125I-PP was used , and bovine PP has an arg-arg bond at the 25th and 26th of 35 peptides. From the position of 125I-material in gel filtration, the destruction of 125I-PP seemed to occur at a position different from the arg-arg bond.
Although the chemical nature and mechanism of action of proteolytic enzymes in ASE are still unknown, it is interesting that the 125I-peptide-degrading enzyme in 
